Abstract
In 90% of cases, women with rheumatoid arthritis suffer a disease flare within 3 months of delivery of their baby. Drug treatment is, therefore, required; however, such therapies have implications for mothers who decide to nurse their infants. Unfortunately, because of a paucity of data, little is known about the transfer of antirheumatic drugs into breast milk, and even less is known about whether small amounts of these agents ingested during nursing could harm the infant. Our review of the literature indicates that paracetamol, prednisone, antimalarial agents, sulfasalazine and most NSAIDs can safely be used by lactating mothers. Expert opinions differ regarding the use of azathioprine, ciclosporin, and methotrexate during lactation because of varying views on the potential for short-term and long-term adverse effects. Evidence regarding the transfer of leflunomide and biologic drugs into breast milk is insufficient; therefore, until more studies are conducted, the use of these drugs in breastfeeding mothers should be restricted. At present, many patients feel they have to choose between postpartum disease control and lactation. Extended studies of the transfer of antirheumatic drugs into breast milk and the resulting consequences are, therefore, urgently needed.
Key Points
-
Most drugs given to a lactating mother appear in breast milk at approximately maternal plasma levels
-
For the drugs discussed in this article, the total daily exposure of the breastfed infant is less than 10% of the therapeutic dose in children
-
NSAIDs, paracetamol, corticosteroids, antimalarial agents, and sulfasalazine are compatible with breastfeeding
-
Infants breastfed by mothers receiving azathioprine, methotrexate or ciclosporin should be monitored for adverse effects
-
Drug exposure can be reduced by timing breastfeeding to avoid peak drug concentrations in milk
-
The lack of data on biologic agents in lactating patients with rheumatoid arthritis means that these patients are often not treated with the most effective therapies
-
Further studies of the transfer of antirheumatic drugs into breast milk and the resulting consequences are urgently needed
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hale TW (2006) Medications and mothers' milk, edn 12. Amarillo, Texas, Hale Publishing
American Academy of Pediatrics Committee on Drugs (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108: 776–789
Begg EJ et al. (1992) Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics. Br J Clin Pharmacol 33: 501–505
Ito S (2000) Drug therapy for breast-feeding women. N Engl J Med 343: 118–126
Lebedevs TH et al. (1991) Excretion of indomethacin in breast milk. Br J Clin Pharmacol 32: 751–754
Beaulac-Baillargeon L and Allard G (1993) Distribution of indomethacin in human milk and estimation of its milk to plasma ratio in vitro. Br J Clin Pharmacol 36: 413–416
Eeg-Olofsson O et al. (1978) Convulsions in a breast-fed infant after maternal indomethacin. Lancet 2: 215
Jamali F and Stevens DR (1983) Naproxen excretion in milk and its uptake by the infant. Drug Intell Clin Pharm 17: 910–911
Townsend RJ et al. (1984) Excretion of ibuprofen into breast milk. Am J Obstet Gynecol 149: 184–186
Walter K and Dilger C (1997) Ibuprofen in human milk. Br J Clin Pharmacol 44: 211–212
Østensen M (1983) Piroxicam in human breast milk. Eur J Clin Pharmacol 25: 829–830
Østensen M et al. (1988) Piroxicam in breast milk after long-term treatment. Eur J Clin Pharmacol 35: 567–569
Todd PA and Sorkin EM (1988) Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 35: 244–285
Wischnik A et al. (1989) The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol 36: 521–524
Hale TW et al. (2004) Transfer of celecoxib into human milk. J Hum Lact 20: 397–403
Gardiner SJ et al. (2006) Quantification of infant exposure to celecoxib through breast milk. Br J Clin Pharmacol 61: 101–104
Notarianni LJ et al. (1987) Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. Br J Clin Pharmacol 24: 63–67
Matheson I et al. (1985) Infant rash caused by paracetamol in breast milk? Pediatrics 76: 651–652
Spigset O and Hagg S (2000) Analgesics and breast-feeding: safety considerations. Paediatr Drugs 2: 223–238
Katz FH and Duncan BR (1975) Letter: Entry of prednisone into human milk. N Engl J Med 293: 1154
McKenzie SA et al. (1975) Secretion of prednisolone into breast milk. Arch Dis Child 50: 894–896
Sagraves R et al. (1981) Prednisone and prednisolone concentrations in the milk of a lactating mother [abstract]. Drug Intell Clin Pharm 15: 484
Greenberger PA et al. (1993) Pharmacokinetics of prednisolone transfer to breast milk. Clin Pharmacol Ther 53: 324–328
Ost L et al. (1985) Prednisolone excretion in human milk. J Pediatr 106: 1008–1011
Coulam CB et al. (1982) Breast-feeding after renal transplantation. Transplant Proc 14: 605–609
Ito S et al. (1993) Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 168: 1393–1399
Grekas DM et al. (1984) Immunosuppressive therapy and breast-feeding after renal transplantation. Nephron 37: 68
Tett SE et al. (1989) Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol 27: 771–779
Nation RL et al. (1984) Excretion of hydroxychloroquine in human milk. Br J Clin Pharmacol 17: 368–369
Østensen M et al. (1985) Hydroxychloroquine in human breast milk. Eur J Clin Pharmacol 28: 357
Costedoat-Chalumeau N et al. (2002) Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 46: 1123–1124
Cimaz R et al. (2004) Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al. Arthritis Rheum 50: 3056–3057
Motta M et al. (2005) Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 25: 86–89
Jarnerot G and Into-Malmberg MB (1979) Sulphasalazine treatment during breast feeding. Scand J Gastroenterol 14: 869–871
Ambrosius Christensen L et al. (1987) Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid. Acta Obstet Gynecol Scand 66: 433–435
Esbjorner E et al. (1987) Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand 76: 137–142
Berlin CM Jr and Yaffe SJ (1980) Disposition of salicylazosulfapyridine (Azulfidine) and metabolites in human breast milk. Dev Pharmacol Ther 1: 31–39
Branski D et al. (1986) Bloody diarrhea—a possible complication of sulfasalazine transferred through human breast milk. J Pediatr Gastroenterol Nutr 5: 316–317
Nelis GF (1989) Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet 1: 383
Moretti ME et al. (2006) Breast-feeding during maternal use of azathioprine. Ann Pharmacother 40: 2269–2272
Gardiner SJ et al. (2006) Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 62: 453–456
Johns DG et al. (1972) Secretion of methotrexate into human milk. Am J Obstet Gynecol 112: 978–980
Nyberg G et al. (1998) Breast-feeding during treatment with cyclosporine. Transplantation 65: 253–255
Moretti ME et al. (2003) Cyclosporine excretion into breast milk. Transplantation 75: 2144–2146
Munoz-Flores-Thiagarajan KD et al. (2001) Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol 97: 816–818
Thiru Y et al. (1997) Successful breast feeding while mother was taking cyclosporin. BMJ 315: 463
Armenti VT et al. (2003) Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 131–141
Østensen M and Eigenmann GO (2004) Etanercept in breast milk. J Rheumatol 31: 1017–1018
Peltier M and James D (2001) Infliximab levels in breast-milk of a nursing Crohn's patient [abstract]. Am J Gastroenterol 96: S312
Förger F et al. (2004) Infliximab in breast milk [abstract]. Lupus 13: 753
Vasiliauskas EA et al. (2005) High serum levels of infliximab detected in the newborn of a mother receiving infliximab during pregnancy [abstract]. Gastroenterology 128: A26
Acknowledgements
Désirée Lie, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Østensen, M., Motta, M. Therapy Insight: the use of antirheumatic drugs during nursing. Nat Rev Rheumatol 3, 400–406 (2007). https://doi.org/10.1038/ncprheum0532
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0532
This article is cited by
-
Managing pregnancy in inflammatory rheumatological diseases
Arthritis Research & Therapy (2011)